米非司酮治疗子宫肌瘤的五年疗效观察  

Effect of mifepristone on the uterine leiomyoma by a five year observation

作　　者：张玮[1] 张燕 张颖杰[1] 

机构地区：[1]首都医科大学附属北京妇产医院,邮政编码100006 [2]门头沟矿务局总医院妇产科

出　　处：《北京医学》2000年第3期169-171,共3页Beijing Medical Journal

摘　　要：目的　观察应用米非司酮治疗子宫肌瘤的效果。　方法　口服米非司酮 12 .5mg,每日1次 ,连续 3个月为一疗程。　结果　 78例中有 6 2例经过 5年临床观察 ,子宫肌瘤体积缩小4 1.81% ,用药过程中均闭经 ,贫血得以纠正。围绝经期可致绝经。因用药后肌瘤缩小 ,界限清楚 ,可作为子宫切除术和肌瘤剔除术术前用药 ,减少术中出血。　结论　经 5年观察 。Objective To study the effect of Mifepristone on the uterine leiomyoma.Methods Seventy eight patients with uterine leiomyoma was observed,each received 12.5mg mifepristone daily for 3 months.Results With 5 years observation,62 patients had a decreased volume of Leiomyoma,average 41.81% off.During treatment,improvement of hemoglobin and amenorrhea occurred.Menopause can even be seen in perimenopausal woman.Because leiomyoma became smaller and easier to be separated,mifepristone could be used before operation to reduce surgery bleeding.Conclusions Through 5 year observation,mifepristone has clinical value.

关 键 词：子宫肌瘤 米非司酮 药物疗法 疗效 

分 类 号：R737.33[医药卫生—肿瘤]